Inventor · disambiguated record
John N. Freskos
Also filed as: FRESKOS JOHN · FRESKOS JOHN N · FRESKOS JOHN NICHOLAS
128 granted patents·32 pending applications·2,235 citations·filing 1988–2019
99Inventor score
Top patents by PatentIndex Score
160 records- 0198US6248775B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1999·Granted Jun 19, 2001·129 cites·18 claims
- 0298US6060476Aα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1994·Granted May 9, 2000·77 cites·12 claims
- 0397US5965588ASulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1998·Granted Oct 12, 1999·66 cites·20 claims
- 0497US5744481Aβ-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1997·Granted Apr 28, 1998·51 cites·47 claims
- 0596US5968942Aα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1994·Granted Oct 19, 1999·61 cites·23 claims
- 0695US6472407B1α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Oct 29, 2002·21 cites·20 claims
- 0795US6335460B1α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Jan 1, 2002·28 cites·26 claims
- 0895US5843946Aα-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1993·Granted Dec 1, 1998·78 cites·14 claims
- 0995US5482947ARetroviral protease inhibitorsFiled 1993·Granted Jan 9, 1996·38 cites·18 claims
- 1094US7320983B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Jan 22, 2008·8 cites·16 claims
- 1194US7176242B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesUPJOHN CO·Filed 2002·Granted Feb 13, 2007·92 cites·20 claims
- 1294US7141609B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2005·Granted Nov 28, 2006·13 cites·20 claims
- 1394US6500832B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Dec 31, 2002·21 cites·20 claims
- 1493US6846954B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Jan 25, 2005·16 cites·14 claims
- 1593US6417387B1α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2001·Granted Jul 9, 2002·24 cites·1 claims
- 1693US5508294ASulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Apr 16, 1996·41 cites·11 claims
- 1792US7115618B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2004·Granted Oct 3, 2006·12 cites·13 claims
- 1892US6534493B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Mar 18, 2003·26 cites·29 claims
- 1992US6384036B1Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted May 7, 2002·22 cites·16 claims
- 2091US7829564B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 9, 2010·4 cites·16 claims
- 2191US7115632B1Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Oct 3, 2006·33 cites·55 claims
- 2291US6924286B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Aug 2, 2005·16 cites·20 claims
- 2390US7339078B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Mar 4, 2008·6 cites·18 claims
- 2490US7161033B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2005·Granted Jan 9, 2007·6 cites·20 claims
- 2590US6646010B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Nov 11, 2003·16 cites·12 claims
- 2690US5610190ARetroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Mar 11, 1997·27 cites·48 claims
- 2790US5510388ASulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Apr 23, 1996·27 cites·16 claims
- 2889US8628751B2Pyrazine derivatives for optical imaging and therapyNEUMANN WILLIAM L·Filed 2010·Granted Jan 14, 2014·8 cites·13 claims
- 2989US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 3089US6172082B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jan 9, 2001·24 cites·49 claims
- 3188US7531538B2α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted May 12, 2009·6 cites·19 claims
- 3288US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 3387US6455581B1α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Sep 24, 2002·20 cites·26 claims
- 3487US6022994ASuccinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1998·Granted Feb 8, 2000·23 cites·40 claims
- 3586USRE43596Eα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsVAZQUEZ MICHAEL L·Filed 2007·Granted Aug 21, 2012·3 cites·15 claims
- 3686US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 3786US5521219ASulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1993·Granted May 28, 1996·54 cites·13 claims
- 3885US8481734B2Pyrazine derivatives and uses thereof, including in medical imaging and visualization applicationsDORSHOW RICHARD B·Filed 2009·Granted Jul 9, 2013·9 cites·19 claims
- 3985US7902195B2Pyridine [3,4-b] pyrazinonesPHARMACIA & UPJOHN CO LLC·Filed 2007·Granted Mar 8, 2011·13 cites·45 claims
- 4085US6313345B1Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1999·Granted Nov 6, 2001·19 cites·172 claims
- 4185US5786483Aα-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jul 28, 1998·26 cites·28 claims
- 4284US6143747ABis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE & CO·Filed 1996·Granted Nov 7, 2000·21 cites·16 claims
- 4384US5703076ARetroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Dec 30, 1997·23 cites·35 claims
- 4483US8871189B2MMP-targeted therapeutic and/or diagnostic nanocarriersMALLINCKRODT LLC·Filed 2012·Granted Oct 28, 2014·5 cites·35 claims
- 4582USRE43802Eα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsVAZQUEZ MICHAEL L·Filed 2011·Granted Nov 13, 2012·1 cites·41 claims
- 4682US7214715B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 8, 2007·18 cites·100 claims
- 4782US6861539B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Mar 1, 2005·10 cites·20 claims
- 4882US6506759B1Retroviral protease inhibitorsMONSANTO CO·Filed 2000·Granted Jan 14, 2003·6 cites·40 claims
- 4982US6316496B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Nov 13, 2001·14 cites·25 claims
- 5082US5760064ASulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1997·Granted Jun 2, 1998·40 cites·77 claims
Showing the top 50 of 160 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →